Identification and Antibacterial Characterization of Endophytic Fungi from Artemisia sieberi

Abstract

Endophytic fungi serve as a reservoir for important secondary metabolites. The current study focused on the antibacterial properties of endophytic fungi isolated from Artemisia sieberi. Initially, six endophytic fungi were isolated and purified from the stem of A. sieberi. Endophytic fungi were identified by morphological characteristics, as well as by molecular identification using 18S rRNA gene sequencing method. All the six isolates were subjected to the preliminary screening for their antibacterial activity against nine important pathogenic bacteria using the disk-diffusion method. Crude extracts of the most active isolate were obtained using ethyl acetate. Antibacterial activity of the ethyl acetate extract was evaluated using well diffusion method on the selected isolate. The antibacterial efficiency of the selected isolate was evaluated by determining the Minimum Inhibitory Concentration (MIC). MIC values were in appreciable quantity against both Gram-positive and Gram-negative bacteria ranging from 3.125 to 6.25 µg/mL and 12.5 to 50 µg/mL, respectively. This result indicated that Gram-positive bacteria were more susceptible to the endophytic fungi extract. Moreover, the molecular identification results revealed that all the isolates belong to Ascomycota and represented Aspergillus and Penicillium genera and three species: A. oryzae (three isolates), A. niger (one isolate), and P. chrysogenum (two isolates). All six endophytic fungi were able to inhibit the growth of at least two of the tested bacteria. Among the isolated strains, isolate AS2, which identified as P. chrysogenum, exhibited the highest antibacterial activity against all nine tested bacteria and was higher than or equal to the positive control against most of the tested bacteria. Future studies are required to isolate and identify these bioactive substances, which can be considered as a potential source for the synthesis of new antibacterial drugs to treat infectious diseases.

The anticancer and antibacterial potential of bioactive secondary metabolites derived From bacterial endophytes in association with Artemisia absinthium

“…Medicinal plants i.e., Artemisia are potential hosts to surplus advantageous endophytes. Artemisia is a genus of plants highly valued as a source of metabolites useful in, for example, medicine and biopesticides 8 , 9 .…”

Optimization and Characterization of Antimicrobial Agents Produced by Marine Aspergillus terreus She05 against Aeromonas hydrophila and other Applications

“…32 A recent study examined the antimicrobial activity of six fungal isolates against 9 bacterial pathogens and the results concluded that more susceptibility to the active compounds was observed for Gram-positive bacteria. 33 Identification of the potent fungal isolate (F3) F 3 w a s e x p o s e d t o m o l e c u l a r characterization and had a multiple alignment with the highest homology using blast search computer based program on NCBI platform. The identified sequence was deposited in NCBI as Aspergillus terreus SHE05 with accession no.…”

Acetylcholine Esterase Inhibitory Effect, Antimicrobial, Antioxidant, Metabolomic Profiling, and an In Silico Study of Non-Polar Extract of The Halotolerant Marine Fungus Penicillium chrysogenum MZ945518

“…Proteus mirabilis is considered a human pathogen which infects the urinary tract, especially in people who have long-term hospitalization [ 34 , 35 ]. Previous research [ 36 ] found that P. chrysogenum has the superior antibacterial activity against nine bacterial species, including Escherichia coli , Acinetobacter baumannii , and Staphylococcus aureus , when compared to Aspergillus oryzae and Aspergillus niger . Furthermore, the fungus inhibited Pseudomonas aeruginosa growth significantly [ 37 ].…”